P30 Use of non‐nucleoside reverse transcriptase inhibitors (NNRTI) in the treatment of HIV and mycobacterial tuberculosis (MTB) infection
Lesley Navaratne(St Thomas' Hospital), Annemiek de Ruiter(ViiV Healthcare (Spain)), Gillian Dean(University Hospitals Sussex NHS Foundation Trust), David Back(University of Liverpool)
Cited by 1
Related Papers
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011
|AIDS|2014|397
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
|AIDS|2002|359
A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population
|Infectious Diseases and Therapy|2018|197